NCT03878095 2026-04-08Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting24 enrolled 12 charts
NCT03212274 2026-02-19Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 MutationsNational Cancer Institute (NCI)Phase 2 Active not recruiting89 enrolled